MedPath

The impact of dipeptidyl peptidase-4 inhibitor on coronary microvascular function in patients with type2 diabetes mellitus

Not Applicable
Conditions
Type 2 diabetic patients with stable angina pectoris who undergo percutaneous coronary intervention
Registration Number
JPRN-UMIN000004390
Lead Sponsor
Cardiovascular Division, Hyogo College of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1) Target lesion is left main coronary artery 2) Patients on hemodialysis 3) Patients with acute coronary syndorome 4) Patients with contraindication of antiplatelet or anticoagulation drug 5) Patients who are uncontrolled diabetes mellitus 6) Patients who are judged by the principal investigator to be ineligible for enrollment in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in index of microcirculatory index
Secondary Outcome Measures
NameTimeMethod
Absolute and percent changes of high-sensitive CRP and adiponectine
© Copyright 2025. All Rights Reserved by MedPath